RPG Life Sciences Ltd

NSE: RPGLIFE · BSE: 532983 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹3,050.60
Market cap: ₹5,045 Cr
Revenue (annual): ₹707.5 Cr
Net profit (annual): ₹115.2 Cr
P/E (TTM): 42.2×Sector 50.4×
Promoter holding: 72.95%+0.00% QoQ
FII holding: 0.95%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 4 Earnings Call 2 Acquisition 2 Price Movement Clarification 1 Financial Results 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

2 Sep 2026 22:34 IST BSE

Earnings Call

RPG Life Sciences Investor Presentation: Key Takeaways

RPG Life Sciences announced a strategic reorganization of its API business into a new subsidiary, RPGAP, involving a PE partnership and two bolt-on acquisitions to drive growth.

Open call summary → Read the filing ↗

28 Jul 2026 20:38 IST NSE

Earnings Call

RPG Life Sciences Investor Presentation: Key Takeaways

RPG Life Sciences reported robust Q1 FY27 results with 15.8% revenue growth and 17.0% PAT growth. Strategy focuses on building a specialty/chronic portfolio and expanding API and international footprint.

Open call summary → Read the filing ↗